New therapeutic modalities in drug discovery and development: Insights & opportunities

Affiliations

¹ Independent Consultant, 79111, Freiburg im Breisgau, Germany (manfred.kansy1@gmail.com).
² Department of Molecular Biotechnology and Health Sciences, University of Torino, Quarello 15, 10135 Torino, Italy (giulia.caron@unito.it).

Editorial

Manfred Kansy et al. ADMET DMPK. 2021.

. 2021 Dec 15;9(4):227-230.

doi: 10.5599/admet.1209. eCollection 2021.

¹ Independent Consultant, 79111, Freiburg im Breisgau, Germany (manfred.kansy1@gmail.com).
² Department of Molecular Biotechnology and Health Sciences, University of Torino, Quarello 15, 10135 Torino, Italy (giulia.caron@unito.it).

No abstract available

Figures

1. Cockburn I.M.. Is the pharmaceutical industry in a productivity crisis? Innovation Policy and the Economy 7 (2006) 1–32. https://doi.org/10.1086/ipe.7.25056188 10.1086/ipe.7.25056188. - DOI
1. Schuhmacher A., Grassmann O., Hinder M.. Changing R&D models in research-based pharmaceutical companies. Journal of Translational Medicine 14 (2016)105-116. https://doi.org/10.1186/s12967-016-0838-4 10.1186/s12967-016-0838-4. - DOI - PMC - PubMed
1. Pamolli F., Magazzini L., Riccaboni M.. The productivity crisis in pharma R &D. Nature Reviews in Drug Discovery 10 (2011) 428-438. https://doi.org/10.1038/nrd3405 10.1038/nrd3405. - DOI - PubMed
1. Feyman Y.. Is Pharmaceutical Productivity in Decline? Maybe Not. Forbes. April 13, 2015. https://www.forbes.com/sites/theapothecary/2015/04/13/is-pharmaceutical-....
1. Hult K.J.. Economics, 2015. Incremental innovation and pharmaceutical productivity. http://terramedica.hsinetwork.com/Hult%20-%20Incremental%20Innovation%20....